<?xml version="1.0" encoding="UTF-8"?>
<ref id="B92">
 <label>92.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Tan</surname>
    <given-names>GS</given-names>
   </name>, 
   <name name-style="western">
    <surname>Lee</surname>
    <given-names>PS</given-names>
   </name>, 
   <name name-style="western">
    <surname>Hoffman</surname>
    <given-names>RM</given-names>
   </name>, 
   <name name-style="western">
    <surname>Mazel-Sanchez</surname>
    <given-names>B</given-names>
   </name>, 
   <name name-style="western">
    <surname>Krammer</surname>
    <given-names>F</given-names>
   </name>, 
   <name name-style="western">
    <surname>Leon</surname>
    <given-names>PE</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ward</surname>
    <given-names>AB</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wilson</surname>
    <given-names>IA</given-names>
   </name>, 
   <name name-style="western">
    <surname>Palese</surname>
    <given-names>P</given-names>
   </name>
  </person-group>
  <year>2014</year>
  <article-title>Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin</article-title>. 
  <source>J Virol</source>
  <volume>88</volume>:
  <fpage>13580</fpage>â€“
  <lpage>13592</lpage>. doi:
  <pub-id pub-id-type="doi">10.1128/JVI.02289-14</pub-id>.
  <pub-id pub-id-type="pmid">25210195</pub-id>
 </mixed-citation>
</ref>
